Antidiabetic effects of chitooligosaccharides on pancreatic islet cells in streptozotocin-induced diabetic rats

World Journal of Gastroenterology

Volumn 13, Issue 5, 2007, Pages 725-731

  Liu, Bing ^a   Liu, Wan Shun ^a   Han, Bao Qin ^a   Sun, Yu Ying ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Chitooligosaccharides; Diabetes mellitus; Oral glucose; Pancreastic islet cells; Streptozotocin; Tolerance test; Two hours plasma glucose

Indexed keywords

ANTIDIABETIC AGENT; CHITOOLIGOSACCHARIDE DERIVATIVE; GLUCOSE; INSULIN; METFORMIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MALE; MICROSCOPY; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL; RADIOIMMUNOASSAY; RAT; STREPTOZOCIN DIABETES; SYMPTOM;

EID: 33847004403     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i5.725     Document Type: Article

References (31)

1. Felt O, Buri P, Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 1998; 24: 979-993
2. Suzuki K, Mikami T, Okawa Y, Tokoro A, Suzuki S, Suzuki M. Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose. Carbohydr Res 1986; 151: 403-408
3. Nishimura K, Nishimura S, Nishi N, Saiki I, Tokura S, Azuma I. Immunological activity of chitin and its derivatives. Vaccine 1984; 2: 93-99
4. Shibata Y, Foster LA, Metzger WJ, Myrvik QN. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect Immun 1997; 65: 1734-1741
5. Hadwiger LA, Beckman JM. Chitosan as a Component of Pea-Fusarium solani Interactions. Plant Physiol 1980; 66: 205-211
6. Chiang MT, Yao HT, Chen HC. Effect of dietary chitosans with different viscosity on plasma lipids and lipid peroxidation in rats fed on a diet enriched with cholesterol. Biosci Biotechnol Biochem 2000; 64: 965-971
7. Park PJ, Je JY, Kim SK. Free radical scavenging activity of chitooligosaccharides by electron spin resonance spectrometry. J Agric Food Chem 2003; 51: 4624-4627
8. Je JY, Park PJ, Kim SK. Free radical scavenging properties of hetero-chitooligosaccharides using an ESR spectroscopy. Food Chem Toxicol 2004; 42: 381-387
9. Tokoro A, Kobayashi M, Tatewaki N, Suzuki K, Okawa Y, Mikami T, Suzuki S, Suzuki M. Protective effect of N-acetyl chitohexaose on Listeria monocytogenes infection in mice. Microbiol Immunol 1989; 33: 357-367
10. Lee SH, Suh JS, Kim HS, Lee JD, Song J, Lee SK. MR evaluation of radiation synovectomy of the knee by means of intra-articular injection of holmium-166-chitosan complex in patients with rheumatoid arthritis: results at 4-month follow-up. Korean J Radiol 2003; 4: 170-178
11. Lin W, Hu X, Zhang W, Rogers WJ, Cai W. Hydrogen peroxide mediates defence responses induced by chitosans of different molecular weights in rice. J Plant Physiol 2005; 162: 937-944
12. Vander P, Vrum KM, Domard A, Eddine El Gueddari N, Moerschbacher BM. Comparison of the ability of partially N-acetylated chitosans and chitooligosaccharides to elicit resistance reactions in wheat leaves Plant Physiol 1998; 118: 1353-1359
13. Park PJ, Je JY, Kim SK. Angiotensin I converting enzyme (ACE) inhibitory activity of hetero-chitooligosaccharides prepared from partially different deacetylated chitosans. J Agric Food Chem 2003; 51: 4930-4934
14. Zhang H, Du Y, Yu X, Mitsutomi M, Aiba S. Preparation of chitooligosaccharides from chitosan by a complex enzyme. Carbohydr Res 1999; 320: 257-260
15. Khan FA, Goforth PB, Zhang M, Satin LS. Insulin activates ATP-sensitive K(+) channels in pancreatic beta-cells through a phosphatidylinositol 3-kinase-dependent pathway. Diabetes 2001; 50: 2192-2198
16. Hopkins WF, Satin LS, Cook DL. Inactivation kinetics and pharmacology distinguish two calcium currents in mouse pancreatic B-cells. J Membr Biol 1991; 119: 229-239
17. Lernmark A. The preparation of, and studies on, free cell suspensions from mouse pancreatic islets. Diabetologia 1974; 10: 431-438
18. Rocheleau JV, Head WS, Nicholson WE, Powers AC, Piston DW. Pancreatic islet beta-cells transiently metabolize pyruvate. J Biol Chem 2002; 277: 30914-30920
19. Patterson GH, Knobel SM, Arkhammar P, Thastrup O, Piston DW. Separation of the glucose-stimulated cytoplasmic and mitochondrial NAD(P)H responses in pancreatic islet beta cells. Proc Natl Acad Sci USA 2000; 97: 5203-5207
20. Tarsi R, Corbin B, Pruzzo C, Muzzarelli RA. Effect of low-molecular-weight chitosans on the adhesive properties of oral streptococci. Oral Microbiol Immunol 1998; 13: 217-224
21. Tarsi R, Muzzarelli RA, Guzman CA, Pruzzo C. Inhibition of Streptococcus mutans adsorption to hydroxyapatite by low-molecular-weight chitosans. J Dent Res 1997; 76: 665-672
22. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113: 909-915
23. Ramachandran A, Snehalatha C, Vijay V, Viswanathan M. Fasting plasma glucose in the diagnosis of diabetes mellitus: a study from southern India. Diabet Med 1993; 10: 811-813
24. Lee CH, Fook-Chong S. Evaluation of fasting plasma glucose as a screening test for diabetes mellitus in Singaporean adults. Diabet Med 1997; 14: 119-122
25. Finch CF, Zimmet PZ, Alberti KG. Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med 1990; 7: 603-610
26. Hollenbeck CB, Chen N, Chen YD, Reaven GM. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 1984; 33: 460-463
27. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987; 64: 1169-1173
28. Bogardus C, Lillioja S, Nyomba BL, Zurlo F, Swinburn B, Esposito-Del Puente A, Knowler WC, Ravussin E, Mott DM, Bennett PH. Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 1989; 38: 1423-1432
29. Engelgau MM, Aubert RE, Thompson TJ, Herman WH. Screening for NIDDM in nonpregnant adults. A review of principles, screening tests, and recommendations. Diabetes Care 1995; 18: 1606-1618
30. Modan M, Harris MI. Fasting plasma glucose in screening for NIDDM in the U.S. and Israel. Diabetes Care 1994; 17: 436-439
31. Kulkarni RN, Winnay JN, Daniels M, Bruning JC, Flier SN, Hanahan D, Kahn CR. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J Clin Invest 1999; 104: R69-R75